Publication | Closed Access

Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1

Lipid PeroxidationOxidative DamageFatty Liver DiseaseOxidative StressMetabolic SyndromeLipid AccumulationHepatotoxicityHealth SciencesBiochemistryLiver PhysiologyPharmacologyDrug-induced Liver InjuryLiverHepatologyPhysiologyMetabolic RegulationMetabolismMedicineCaffeic Acid